The result rise in accumulation of cur shares is encouraging for all us longs but is anyone else wondering what's taking so long to start the ALS phase 2? I understand that this trials can't start over night and require extensive recruitment; however, after CUR's public participation in the FDA meeting to discuss a more efficient and speedy treatment process for diseases like ALS you can't help but wonder what is taking so long to get started. For the record...I'm long and am a firm believer in this stock and their science. Just wanted to hear other longs thoughts on when we might see phase 2 trial commencement. Oh yeah....and heretostayforever.....go F yourself. At least we got rid of Chen. Haha
The other thing holding up the start is the sites doing the surgeries. The University of Michigan like Emory is having to get the program approved by the board. Even though it is pretty much a done deal they want to make it look like they are taking their time to do a real investigation prior to authorizing the start of the program.
Good Luck To All Patients, Their Families & Investors (especially longs)
Don't worry, big news is coming.
CUR is giving this other company a chance to buy shares priced at $1.25 (about 750k shares) and usually when companies do "repricing of share" offers to other companies it means BIG news is around the corner.
My understanding is that the FDA protocol requires that the Phase II patient be monitored for 3 months prior to the surgery, hence, the surgeries are supposed to begin sometime this month.
That's incorrect. The lead-in observation is 1-month, according to the trial design posted on NIH. Enrollment status on the website was changed on 6-04-13 to, enrolling my invitation, from not yet recruiting. 7-4 would be a 1-month post. Should see surgeries any day, assuming sites have all IRB approval.
mmbudda, thanks for the info re the 3 month paitent monitoring period before surgeries can begin. I have been wondering why trials have not begun, at least at Emory. At the FDA ALS hearing early in the year, Dr. Jon Glass sounded to me like he was most anxious and ready to get on with treatments. I had the feeling he would have knocked them out one a day, it that were possible. Dr. Feldman is not one to let grass grow either. So I guess we have to trust the trials will start as soon as all is ready.
CUR's position may be different. They may try to prove that 3 month wait may be too long once ALS is discovered. The treatment effectiveness is great ... when "sooner is better" policy. Safety trial proved it. ALS may be death sentence for most patients. How will the FDA change its policy. Paradigm shift indeed.
Sentiment: Strong Buy